Core Tech Solutions
Stage
Incubator/Accelerator | DeadAbout Core Tech Solutions
Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Core Tech Solutions Patents
Core Tech Solutions has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/17/2006 | 2/2/2016 | Acetylcholinesterase inhibitors, Alzheimer's disease, Amines, Organophosphate insecticides, Dosage forms | Grant |
Application Date | 8/17/2006 |
|---|---|
Grant Date | 2/2/2016 |
Title | |
Related Topics | Acetylcholinesterase inhibitors, Alzheimer's disease, Amines, Organophosphate insecticides, Dosage forms |
Status | Grant |
Latest Core Tech Solutions News
Jan 29, 2020
Ontogenetic is a developmental history of an organism, which includes the study of cognitive, physical, social, and emotional development, which can be attributed to experience with the individuals and the environment within the environment. Ontogenetic is a vast subject and continuous research in the field is expanding its applications. Increasing human and animal population is one of the major factors affecting the market growth, positively. Furthermore, increasing funding for research is one of the major driving factors of the market. Epilepsy is the disorder of a nervous system. According to the last updated report on February 2017 by World Health Organization (WHO), around 50 million people are affected with epilepsy globally, and it affects people of all ages. Get Sample Copy of this Report: Symbiotic Devices World Ontogenetic Market 2019 Global Industry research report represents the historical overview of current market Situation and forecast 2019-2025. Additionally, this report explorers Ontogenetic market size, trends, share, growth, development plans, Investment Plan, cost structure and drivers analysis. In this Ontogenetic market report, industry trends have been explained on the macro level which makes it possible outline market landscape and probable future issues. The Global Ontogenetic market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Ontogenetic market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Inquire more or share questions if any on this report @ The report also focuses on global major leading industry players of Ontogenetic market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Ontogenetic development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With tables and figures helping analyze worldwide Air Cargo Security market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market Order a copy of Ontogenetic Market Report 2019 @
Core Tech Solutions Frequently Asked Questions (FAQ)
Where is Core Tech Solutions's headquarters?
Core Tech Solutions's headquarters is located at 50 Lake Drive, East Windsor.
What is Core Tech Solutions's latest funding round?
Core Tech Solutions's latest funding round is Incubator/Accelerator.
Who are the investors of Core Tech Solutions?
Investors of Core Tech Solutions include High Technology Small Business Incubator.
Who are Core Tech Solutions's competitors?
Competitors of Core Tech Solutions include Mirus Bio, Brainsgate, PolyPid, Corium International, EZRA Innovations, MonoSol Rx, Sagent Pharmaceuticals, Critical Pharmaceuticals, Capnia, Catalent and 21 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Core Tech Solutions to Competitors
Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.
Selective Amplifier Genes offers artificial genes that improve the functions of vectors for use in blood disorders
Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.
MedManage Systems, Inc. aims to provide drug sampling solutions. The company's OmniSampleSM Solution aims to allow pharmaceutical companies to intensify physician use of trial medications, thereby increasing product revenues.
Glide Pharma, formerly Caretek Medical, is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of pharmaceuticals and vaccines using its Glide SDI - the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments.
EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system. Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical ingredients (API), DSC possesses the ability to change the chemical moiety of existing drugs and better extend release rates.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
